Clinical Trials Directory

Trials / Unknown

UnknownNCT05374694

Angina, Physiology, Biology (ANgina, FIsiologia BIOlogia)

Epigenetic Characterization of Angina Pectoris According to the Affected Coronary Compartment: Relationship Between Invasive Physiological Coronary Evaluation and Micro-RNAs

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Hospital Arnau de Vilanova · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Relationship between invasive physiological assessment with FFR and IMR and biological markers as micro-RNA's according to coronary vascular compartiment affected (Group 1: Macrovasculature + / Microvasculature +; Group 2: Macrovasculature + / Microvasculature -; Group 3: Macrovasculature - / Microvasculature +; Group 4: Macrovasculature - / Microvasculature -). Also, biological markers will be related with presence of microvascular spasm or macrovascular spasm (Group 5).

Detailed description

Patients with chest pain suggestive of angina after ruling out other cardiac and non-cardiac causes, referred for invasive coronary angiography, will be evaluated by coronary angiography and invasive coronary physiological assessment by determining FFR and IMR and by performing a vasoreactivity test with acetylcholine. A relationship will be established between the invasive physiological assessment with FFR and IMR and biological markers such as micro-RNA's according to the affected coronary vascular compartment (Group 1: Macrovasculature + / Microvasculature +; Group 2: Macrovasculature + / Microvasculature -; Group 3 : Macrovasculature - / Microvasculature +; Group 4: Macrovasculature - / Microvasculature -). In addition, the biological markers will be related to the presence of microvascular spasm or macrovascular spasm (Group 5). Finally, among other biological markers, the following miRNAs will be compared. These miRNA's present consistent data in the literature about their over or underexpression.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPhysiological invasive coronary evaluationPerformance of FFR, IMR and acetylcholine test (Only patients in groups 3 and 4 will undergo the acetylcholine test)

Timeline

Start date
2022-05-08
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2022-05-16
Last updated
2022-10-19

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05374694. Inclusion in this directory is not an endorsement.